318 related articles for article (PubMed ID: 26899197)
1. Lipotoxicity in obesity and diabetes-related cardiac dysfunction.
Zlobine I; Gopal K; Ussher JR
Biochim Biophys Acta; 2016 Oct; 1861(10):1555-68. PubMed ID: 26899197
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism and signaling in cardiac lipotoxicity.
D'Souza K; Nzirorera C; Kienesberger PC
Biochim Biophys Acta; 2016 Oct; 1861(10):1513-24. PubMed ID: 26924249
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
[TBL] [Abstract][Full Text] [Related]
5. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
Ussher JR
Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
[TBL] [Abstract][Full Text] [Related]
6. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
[TBL] [Abstract][Full Text] [Related]
7. Lipotoxicity in type 2 diabetic cardiomyopathy.
van de Weijer T; Schrauwen-Hinderling VB; Schrauwen P
Cardiovasc Res; 2011 Oct; 92(1):10-8. PubMed ID: 21803867
[TBL] [Abstract][Full Text] [Related]
8. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyopathy in obesity, insulin resistance and diabetes.
Nakamura M; Sadoshima J
J Physiol; 2020 Jul; 598(14):2977-2993. PubMed ID: 30869158
[TBL] [Abstract][Full Text] [Related]
10. Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation.
Wu M; Tan J; Cao Z; Cai Y; Huang Z; Chen Z; He W; Liu X; Jiang Y; Gao Q; Deng B; Wang J; Yuan W; Zhang H; Chen Y
Redox Biol; 2024 Jul; 73():103184. PubMed ID: 38718533
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity.
Karwi QG; Sun Q; Lopaschuk GD
Cells; 2021 Nov; 10(11):. PubMed ID: 34831481
[TBL] [Abstract][Full Text] [Related]
12. Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.
Kok BP; Brindley DN
Heart Fail Clin; 2012 Oct; 8(4):643-61. PubMed ID: 22999246
[TBL] [Abstract][Full Text] [Related]
13. Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes.
Haffar T; Bérubé-Simard F; Bousette N
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):73-8. PubMed ID: 26546819
[TBL] [Abstract][Full Text] [Related]
14. Lipid accumulation in non-adipose tissue and lipotoxicity.
van Herpen NA; Schrauwen-Hinderling VB
Physiol Behav; 2008 May; 94(2):231-41. PubMed ID: 18222498
[TBL] [Abstract][Full Text] [Related]
15. Manifestations and mechanisms of myocardial lipotoxicity in obesity.
Sletten AC; Peterson LR; Schaffer JE
J Intern Med; 2018 Nov; 284(5):478-491. PubMed ID: 29331057
[TBL] [Abstract][Full Text] [Related]
16. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
Zhang L; Keung W; Samokhvalov V; Wang W; Lopaschuk GD
Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
[TBL] [Abstract][Full Text] [Related]
17. Profile of cardiac lipid metabolism in STZ-induced diabetic mice.
Li W; Yao M; Wang R; Shi Y; Hou L; Hou Z; Lian K; Zhang N; Wang Y; Li W; Wang W; Jiang L
Lipids Health Dis; 2018 Oct; 17(1):231. PubMed ID: 30301464
[TBL] [Abstract][Full Text] [Related]
18. High fat diet induced diabetic cardiomyopathy.
Dirkx E; Schwenk RW; Glatz JF; Luiken JJ; van Eys GJ
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):219-25. PubMed ID: 21571515
[TBL] [Abstract][Full Text] [Related]
19. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets.
Sung MM; Hamza SM; Dyck JR
Antioxid Redox Signal; 2015 Jun; 22(17):1606-30. PubMed ID: 25808033
[TBL] [Abstract][Full Text] [Related]
20. [Diabetic cardiomyopathy].
Huang YQ; Wang X; Kong W
Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
